Industry Adoption of Organoids and Organs‐on‐Chip Technology: Toward a Paradox of Choice
KA Homan - Advanced biology, 2023 - Wiley Online Library
During the last decade, organoid and organs‐on‐chip technologies have significantly
enhanced the ability to model human biology in vitro. For the pharmaceutical industry, this …
enhanced the ability to model human biology in vitro. For the pharmaceutical industry, this …
Industry Adoption of Organoids and Organs-on-Chip Technology: Toward a Paradox of Choice.
KA Homan - Advanced Biology, 2023 - europepmc.org
During the last decade, organoid and organs-on-chip technologies have significantly
enhanced the ability to model human biology in vitro. For the pharmaceutical industry, this …
enhanced the ability to model human biology in vitro. For the pharmaceutical industry, this …
Industry Adoption of Organoids and Organs-on-Chip Technology: Toward a Paradox of Choice
KA Homan - Advanced biology, 2023 - pubmed.ncbi.nlm.nih.gov
During the last decade, organoid and organs-on-chip technologies have significantly
enhanced the ability to model human biology in vitro. For the pharmaceutical industry, this …
enhanced the ability to model human biology in vitro. For the pharmaceutical industry, this …
Industry Adoption of Organoids and Organs‐on‐Chip Technology: Toward a Paradox of Choice.
KA Homan - Advanced Biology, 2023 - search.ebscohost.com
During the last decade, organoid and organs‐on‐chip technologies have significantly
enhanced the ability to model human biology in vitro. For the pharmaceutical industry, this …
enhanced the ability to model human biology in vitro. For the pharmaceutical industry, this …